New technology allows control of gene therapy doses
Scientists at Scripps Research in Jupiter have developed a special molecular switch that could be embedded into gene therapies to allow doctors to control dosing.
Scientists at Scripps Research in Jupiter have developed a special molecular switch that could be embedded into gene therapies to allow doctors to control dosing.
Alan Aspuru-Guzik, director of Acceleration Consortium at the University of Toronto, discusses his research in targeting an ‘undruggable’ cancer protein with the help from AI…
Session I Chairs: Monika Holubová (Charles University, Czech Republic), Dominik Schneidawind (University Hospital Zurich, Switzerland) Charles University, Czech Republic CiRT co-founder University of Pennsylvania, United…
Scientists used implanted fat cells to gobble up available nutrients around cancer tumors, starving the tumors to death.
“A really big question that, at least I ask myself, is, ‘How do we become who we are?’” University of Virginia psychology graduate student Olivia…
As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world…
Shen et al. investigate the use of Lactobacillus plantarum, a commensal bacterial strain, as a chassis for targeting the olfactory mucosa to facilitate precise nose-to-brain delivery…
School closures reduced the impact of COVID-19 in most countries but had negative effects in some, Monash University-led research encompassing 74 countries has found.
Nature Biotechnology – An AI-generated small-molecule inhibitor treats fibrosis in vivo and in phase I clinical trials.
Nature Biotechnology – An AI-generated small-molecule inhibitor treats fibrosis in vivo and in phase I clinical trials.
Nature Biotechnology – Adipocytes can be isolated, genetically manipulated, and then reimplanted. In this study, these properties were leveraged to engineer adipocytes that can outcompete…